ResMed|'s revenue was $5.65bn in fiscal 2026, up 9.9% on the year before. Since fiscal 2010 ($1.09bn) it has grown at a compound 10.8% a year. Over the last twelve months it was $5.73bn.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to June 30, 2026
Sleep and Breathing Health$5B
Residential Care Software$676M
Segments
Line of business
Revenue
Share
YoY
Sleep and Breathing Health
$5B
88.0%
▲ 10.5%
Residential Care Software
$676M
12.0%
▲ 5.4%
Sleep and Breathing Health$5B
Residential Care Software$676M
Products and services
Line of business
Revenue
Share
YoY
Sleep and Breathing Health
$5B
88.0%
▲ 10.5%
Residential Care Software
$676M
12.0%
▲ 5.4%
United States$3.6B
Outside the US$2.1B
Geography
Region
Revenue
Share
YoY
United States
$3.6B
63.0%
▲ 8.4%
Outside the US
$2.1B
37.0%
▲ 12.4%
From ResMed|'s 10-K filed August 13, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Health Care Equipment: the closest covered companies by revenue. Last twelve months.
Figures from ResMed|'s SEC filings (10-K and 10-Q), retrieved October 30, 2026.
How we read and check them: methodology and data sources.
Not investment advice. Back to ResMed|.
